Filing Details
- Accession Number:
- 0001827672-23-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-16 16:48:55
- Reporting Period:
- 2023-06-14
- Accepted Time:
- 2023-06-16 16:48:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1819790 | Tarsus Pharmaceuticals Inc. | TARS | Biological Products, (No Disgnostic Substances) (2836) | 814717861 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1827672 | R. Bobak Azamian | C/O Tarsus Pharmaceuticals, Inc. 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618 | President/Ceo And Board Chair | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-06-14 | 9,000 | $18.58 | 1,031,006 | No | 4 | S | Indirect | By the Bobak Azamian Living Trust established April 16, 2018 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By the Bobak Azamian Living Trust established April 16, 2018 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,597 | Direct |
Footnotes
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.
- The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.17 to $18.95. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.
- This Form 4 includes the correction of a prior inadvertent administrative error in the amount of securities directly held by the Reporting Person.
Billionaire Hedge Funds
